- Conditions: Cognition Disorders; Cocaine Dependence; ADHD
Intervention: Procedure: repetitive Transcranial Magnetic Stimulation (rTMS)
Sponsors: University of Sao Paulo General Hospital; University of Sao Paulo General Hospital
Recruiting - verified May 2012 - Condition: ADHD
Intervention: Behavioral: probabilistic choice
Sponsors: Shaare Zedek Medical Center; Shaare Zedek Medical Center
Not yet recruiting - verified April 2012 - Conditions: Bipolar Disorder; Attention Deficit Disorder With Hyperactivity; Attention Deficit Disorder Without Hyperactivity; Generalized Anxiety Disorder; Healthy
Intervention:
Sponsors: Bradley Hospital; Bradley Hospital; National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Condition: Attention-deficit/Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine dimesylate; Drug: Methylphenidate Hydrochloride; Drug: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Condition: Attention-deficit/Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine dimesylate; Drug: Methylphenidate Hydrochloride; Drug: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Conditions: Sleep Apnea, Obstructive; Sleep Apnea Syndromes; Child Behavior Disorders; Attention Deficit Disorder With Hyperactivity; Disorders of Excessive Somnolence
Interventions: Procedure: CPAP treatment; Other: No CPAP treatment
Sponsors: University of Michigan; University of Michigan; National Heart, Lung, and Blood Institute (NHLBI); Michigan Technological University
Recruiting - verified March 2012 - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Behavioral: Teacher Help for ADHD
Sponsors: Dalhousie University; Dalhousie University
Recruiting - verified March 2012 - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Behavioral: IBBS
Sponsors: Yale University; Yale University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Hamden Public Schools, Hamden, CT; C8Sciences; PAXIS Institute; BeCaid, Beijing, China; Peking University, Beijing, China; Capital Medical University, Beijing, China; Beijing Physical Education & Skill College, Beijing, China
Recruiting - verified March 2012 - Conditions: Attention Deficit/Hyperactivity Disorder Combined Type; ADHD Predominantly Inattentive Type; ADHD Predominantly Hyperactivity Type; ADHD-not Other Specified
Intervention: Drug: Methylphenidate- Ritalin IR (Immediate Release)
Sponsors: Sheba Medical Center; Sheba Medical Center
Recruiting - verified March 2012 - Conditions: Attention Deficit Hyperactivity Disorder; Delayed Circadian Rhythm Disorder
Intervention: Device: Polarized glasses designed to filter out blue light
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified March 2012 - Conditions: Adolescent Substance Abuse; Attention Deficit Hyperactivity Disorder
Intervention: Behavioral: Medication integration protocol
Sponsors: The National Center on Addiction and Substance Abuse at Columbia University; The National Center on Addiction and Substance Abuse at Columbia University
Recruiting - verified February 2012 - Conditions: Attention Deficit Hyperactivity Disorder (ADHD); Executive Function Deficits (EFD)
Interventions: Drug: Placebo; Drug: Memantine Hydrochloride; Drug: OROS-Methylphenidate
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; American Professional Society of ADHD and Related Disorders
Not yet recruiting - verified April 2012 - Condition: ADHD
Intervention:
Sponsors: Hillel Yaffe Medical Center; Hillel Yaffe Medical Center
Not yet recruiting - verified February 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Other: questionary; Other: questionary
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified January 2012 - Condition: Mental Disorders
Interventions: Drug: YY-162; Drug: Placebo
Sponsors: Yuyu Pharma, Inc.; Yuyu Pharma, Inc.
Recruiting - verified October 2011 - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Other: Preference and Goal Instrument
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia
Not yet recruiting - verified December 2011 - Condition: Epilepsy
Interventions: Other: ADHD Rating Scale-IV; Other: ADHD Rating Scale-IV
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified November 2011 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Device: sham computerised training of working memory; Device: Computerised training of working memory ( Flex)
Sponsors: Karolinska Institutet; Karolinska Institutet
Not yet recruiting - verified November 2011 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: TC-5619-238 5mg; Drug: TC-5619-238 25mg; Drug: Placebo
Sponsors: Targacept Inc.; Targacept Inc.
Recruiting - verified May 2012 - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention:
Sponsors: NHS Tayside; NHS Tayside; Zentralinstitut fuer Seelische Gesundheit; Universita degli Studi di Cagliari; Vadaskert Child and Adolescent Psychiatry Clinic
Recruiting - verified February 2012 - Conditions: Attention-Deficit/Hyperactivity Disorder; ADHD
Interventions: Drug: TD-9855; Drug: TD-9855; Drug: Placebo
Sponsors: Theravance; Theravance
Recruiting - verified December 2011 - Conditions: Autism Spectrum Disorder; Attention Deficit/Hyperactivity Disorder; Developmental Delay
Intervention:
Sponsors: The Cleveland Clinic; Thomas W. Frazier, Ph.D; IntegraGen SA
Recruiting - verified March 2012 - Condition: Attention Deficit Hyperactivity Disorder
Intervention:
Sponsors: Hallym University Medical Center; Hallym University Medical Center
Recruiting - verified February 2010 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: Training Executive, Attention and Motor Skills (TEAMS); Behavioral: Parent support and education
Sponsors: Queens College, The City University of New York; Queens College, The City University of New York
Recruiting - verified October 2011 - Conditions: Attention Deficit Hyperactivity Disorder; Substance Use Disorders
Intervention: Behavioral: cognitive behavioral therapy for treating ADHD symptoms
Sponsors: Arkin; Arkin; NutsOhra Funding
Recruiting - verified September 2011 - Conditions: Major Depressive Disorder; Attention-deficit Hyperactivity Disorder (ADHD)
Intervention:
Sponsors: Wake Forest University Baptist Medical Center; Wake Forest University Baptist Medical Center
Recruiting - verified September 2011 - Condition: Borderline Personality Disorder
Intervention: Drug: methylphenidate
Sponsors: Shalvata Mental Health Center; Shalvata Mental Health Center
Not yet recruiting - verified August 2011 - Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: Lisdexamfetamine dimesylate
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; Shire Development LLC
Not yet recruiting - verified August 2011 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine; Drug: Placebo
Sponsors: Columbia University; Columbia University; Shire Development LLC
Not yet recruiting - verified August 2011 - Conditions: Attention Deficit Hyperactivity Disorder (ADHD); Deficient Emotional Self-Regulation (DESR)
Interventions: Drug: OROS-Methylphenidate; Drug: Omega-3 Fatty Acids
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Conditions: Attention Deficit Hyperactivity Disorder; Sleep Onset Insomnia
Interventions: Drug: Melatonin; Drug: Methylphenidate
Sponsors: Assaf-Harofeh Medical Center; Assaf-Harofeh Medical Center
Recruiting - verified July 2011 - Condition: Attention-Deficit/Hyperactivity Disorder
Intervention: Device: EMS 7500 Digital Muscle Stimulator
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified June 2011 - Conditions: Attention Deficit Hyperactivity Disorder; Attention Deficit Disorder
Intervention: Behavioral: MIP Protocol
Sponsors: The National Center on Addiction and Substance Abuse at Columbia University; The National Center on Addiction and Substance Abuse at Columbia University; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified February 2012 - Condition: Impulsive Aggression Comorbid With ADHD
Interventions: Drug: Molindone; Drug: Placebo
Sponsors: Supernus Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.
Recruiting - verified August 2011 - Conditions: Attention Deficit Hyperactivity Disorder; ADHD; Bipolar Disorder
Intervention:
Sponsors: King's College London; King's College London; South London and Maudsley NHS Trust (SLAM)
Recruiting - verified April 2012 - Condition: Attention-Deficit / Hyperactivity Disorder
Intervention: Drug: JNS001
Sponsors: Janssen Pharmaceutical K.K.; Janssen Pharmaceutical K.K.
Recruiting - verified May 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Other: CHICA ADHD Module; Other: CHICA ADHD Control
Sponsors: Indiana University; Indiana University; National Library of Medicine (NLM)
Recruiting - verified March 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Device: BCI; Device: BCI; Device: BCI
Sponsors: National Healthcare Group, Singapore; National Healthcare Group, Singapore; Duke-NUS Graduate Medical School; Agency for Science, Technology and Research; Singapore Clinical Research Institute; National Neuroscience Institute
Recruiting - verified December 2011 - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Drug: Lisdexamfetamine dimesylate
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified November 2011 - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Other: Multifaceted cognitive training
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Condition: Attention Deficit/Hyperactivity Disorder
Interventions: Drug: Placebo; Drug: RIT124D; Drug: RIT124D; Drug: RIT124D
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Extended-release Guanfacine Hydrochloride; Drug: Atomoxetine Hydrochloride; Drug: Placebo Comparator
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: Lovaza; Dietary Supplement: Placebo (corn oil).
Sponsors: Maimonides Medical Center; Maimonides Medical Center; GlaxoSmithKline
Recruiting - verified August 2011 - Condition: Attention-deficit/Hyperactivity Disorder
Intervention: Drug: methylphenidate (Ritalin®)
Sponsors: Hospital de Clinicas de Porto Alegre; Hospital de Clinicas de Porto Alegre; Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified August 2011 - Condition: Pervasive Development Disorders
Interventions: Drug: extended-release guanfacine; Other: placebo
Sponsors: Yale University; Yale University; Massachusetts General Hospital; Seattle Children's Hospital; University of California, Los Angeles; National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Attention Deficit/Hyperactivity Disorder
Interventions: Behavioral: Collaborative Care Plus; Behavioral: Traditional Collaborative Care
Sponsors: Boston Medical Center; Boston Medical Center; Codman Square Health Center; Dorchester House Health Center
Recruiting - verified October 2010 - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Device: treatment by HLPFC coil
Sponsors: Brainsway; Brainsway
Recruiting - verified July 2011 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Device: CarChipPro; Behavioral: Driver's Education; Behavioral: STEER Program; Other: Driving Simulator Practice
Sponsors: State University of New York at Buffalo; State University of New York at Buffalo
Recruiting - verified July 2011 - Condition: Attention Deficit Hyperactivity Disorder
Intervention:
Sponsors: Meir Medical Center; Meir Medical Center
Not yet recruiting - verified August 2011 - Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Other: Polysomnography; Other: Maintenance Wakefulness Test; Behavioral: Neuropsychological evaluation; Other: Driving test on a simulator
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux
Recruiting - verified October 2011 - Condition: Attention-deficit/Hyperactivity Disorder
Intervention: Drug: Guanfacine (sustained release)
Sponsors: Neurology Group of Bergen County, P.A.; Neurology Group of Bergen County, P.A.; Shire Development LLC
Recruiting - verified July 2011 - Condition: ADHD
Intervention: Other: ADHD Collaborative
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; Nationwide Children's Hospital
Recruiting - verified February 2012 - Conditions: Attention Deficit Hyperactivity Disorder; Reading Difficulty or Disability
Interventions: Drug: Methylphenidate; Behavioral: Intensive reading instruction; Behavioral: Parent Training; Drug: Mixed Salt Amphetamine; Drug: Atomoxetine; Drug: Guanfacine
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: ADHD
Intervention: Drug: lisdexamfetamine
Sponsors: Florida International University; Florida International University
Recruiting - verified April 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Other: Computerized Progressive Attention Training; Other: Sham Comparator Cognitive Training
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Conditions: Smoking; ADHD
Intervention:
Sponsors: Duke University; Duke University; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Attention Deficit Hyperactivity Disorder
Intervention:
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified November 2011 - Condition: Attention-Deficit/Hyperactivity Disorder
Intervention:
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany; MediTECH Electronic GmbH; AudioProfiling, Dr. Joerg Langner
Recruiting - verified February 2012 - Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine Dimesylate; Drug: Atomoxetine Hydrochloride
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
Sponsors: University Hospital, Strasbourg, France; University Hospital, Strasbourg, France
Recruiting - verified August 2011 - Condition: ADHD
Intervention:
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified February 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Other: CBT plus treatment as usual; Other: Treatment as usual
Sponsors: South London and Maudsley NHS Foundation Trust; South London and Maudsley NHS Foundation Trust
Recruiting - verified December 2011 - Condition: Attention-deficit/Hyperactivity Disorder
Interventions: Drug: Extended-release Guanfacine Hydrochloride; Other: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified December 2011 - Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: Extended-release Guanfacine Hydrochloride; Other: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Conditions: Obsessive Compulsive Disorder; Body Dysmorphic Disorder; Tourette Syndrome; Trichotillomania; Panic Disorder; Social Phobia; Generalized Anxiety Disorder; Depression; Post-Traumatic Stress Disorder; Attention Deficit Hyperactivity Disorder; Eating Disorder; Specific Phobia; General Medical Condition
Intervention: Behavioral: Cognitive behavioral therapy (CBT)
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified March 2012 - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Osmotic Release Methylphenidate
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; ElMindA Ltd
Recruiting - verified October 2011 - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Dietary Supplement: Omega-3 fatty acids
Sponsors: University of Ulm; University of Ulm
Recruiting - verified February 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Dietary Supplement: Compound Natural Health Product; Dietary Supplement: Placebo
Sponsors: The Canadian College of Naturopathic Medicine; The Canadian College of Naturopathic Medicine; Health Canada; Centre for Addiction and Mental Health; SickKids Foundation
Not yet recruiting - verified October 2011 - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Behavioral: Cognitive Behavioral Therapy (CBT)
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Conditions: Attention Deficit Hyperactivity Disorder; Glucose Intolerance; Obesity
Intervention: Drug: Lis-dexamphetamine
Sponsors: Duke University; Duke University; Shire Development LLC
Recruiting - verified March 2012 - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: LY2216684
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Behavioral: Challenging Horizons Program (CHP) after-school model; Behavioral: Challenging Horizons Program (CHP) consultation model
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Condition: Attention Deficit/Hyperactivity Disorder
Intervention: Other: Physical activity
Sponsors: Meir Medical Center; Meir Medical Center
Not yet recruiting - verified March 2012 - Conditions: ADHD; Attention Deficit Hyperactivity Disorder
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Shire Development LLC
Recruiting - verified July 2011 - Condition: Attention Deficit/Hyperactivity Disorder
Interventions: Drug: Short Acting Methylphenidate; Drug: Long Acting Methylphenidate
Sponsors: BRC Operations Pty. Ltd.; BRC Operations Pty. Ltd.
Recruiting - verified January 2012 - Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Other: CATMH intervention
Sponsors: Seattle Children's Hospital; Seattle Children's Hospital; University of Washington
Recruiting - verified April 2012 - Conditions: Conduct Disorder; Attention Deficit Hyperactivity Disorder; Oppositional Defiant Disorder
Interventions: Dietary Supplement: Omega-3; Behavioral: Social Skills Training; Other: Standard Treatment (or TAU in Child Guidance Clinic)
Sponsors: National Healthcare Group, Singapore; National Healthcare Group, Singapore; Nanchang University; University of Pennsylvania; National University, Singapore; Duke-NUS Graduate Medical School; Alexandra Hospital, Singapore; Singapore Institute for Clinical Studies
Recruiting - verified June 2010 - Conditions: Mood Disorder; Mental Disorder Diagnosed in Childhood; Attention Deficit and Disruptive Behavior Disorder; Attention Deficit Hyperactivity Disorder
Interventions: Drug: Citalopram; Drug: Methylphenidate
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified July 2011 - Conditions: Attention Deficit Hyperactivity Disorder; Nicotine Dependence
Interventions: Drug: Lis-dexamphetamine (LDX; Vyvanse) and Transdermal Nicotine Patch; Drug: Placebo and transdermal nicotine patch
Sponsors: Duke University; Duke University; Shire Development LLC
Recruiting - verified June 2011 - Conditions: Attention Deficit Hyperactivity Disorder; Autism Spectrum Disorder
Intervention:
Sponsors: Sheba Medical Center; Sheba Medical Center
Recruiting - verified June 2011 - Conditions: Attention Deficit Hyperactivity Disorder; Dyslexia
Interventions: Drug: Atomoxetine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified February 2012 - Conditions: Autism; Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Atomoxetine; Behavioral: Parent management training (PMT); Drug: Placebo
Sponsors: University of Rochester; University of Rochester; National Institute of Mental Health (NIMH)
Recruiting - verified March 2009 - Conditions: Autism; Pervasive Developmental Disorder Not Otherwise Specified; Asperger's Disorder; Attention Deficit Hyperactivity Disorder
Interventions: Drug: atomoxetine; Drug: Placebo; Behavioral: Parent Management Training
Sponsors: University of Rochester; University of Rochester; University of Pittsburgh; Ohio State University
Recruiting - verified August 2011 - Condition: Pediatric ADHD
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Condition: ADHD
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Conditions: Adult Attention Deficit Hyperactivity Disorder; Cocaine Dependence
Interventions: Drug: Placebo; Drug: Adderall-XR; Drug: Adderall-XR
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified April 2012 - Condition: Oppositional-Defiant Disorder
Interventions: Behavioral: Parent management training (PMT); Behavioral: Collaborative problem solving (CPS); Behavioral: Waitlist control
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Ritalin; Drug: Placebo
Sponsors: McGill University; McGill University
Recruiting - verified February 2012 - Conditions: Fetal Alcohol Syndrome; Attention Deficit Disorder With Hyperactivity (ADHD); Attention Deficit Disorder (ADD)
Interventions: Drug: Strattera; Drug: Placebo
Sponsors: University of Oklahoma; University of Oklahoma; Mark L. Wolraich, M.D.; Eli Lilly and Company
Recruiting - verified February 2012 - Condition: ADHD
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified July 2011 - Conditions: Attention Deficit Disorder With Hyperactivity; Mental Disorders Diagnosed in Childhood; Conduct Disorder
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified October 2011 - Conditions: Autoimmune Disease; Congenital Adrenal Hyperplasia; Healthy; Mental Disorder Diagnosed in Childhood; Neurologic Manifestations
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified September 2011
 |
Join Clinical Trials for Attention-Deficit Hyperactivity Disorder (ADD and ADHD) |
